| Towards tuberculosis elimination: an action framework for low-incidence countries K Lönnroth, GB Migliori, I Abubakar, L D'Ambrosio, G De Vries, R Diel, ... European Respiratory Journal 45 (4), 928-952, 2015 | 663 | 2015 |
| Hepatitis E virus antibody prevalence among persons who work with swine J Drobeniuc, MO Favorov, CN Shapiro, BP Bell, EE Mast, A Dadu, ... The Journal of infectious diseases 184 (12), 1594-1597, 2001 | 323 | 2001 |
| Multidrug-resistant tuberculosis in Belarus: the size of the problem and associated risk factors A Skrahina, H Hurevich, A Zalutskaya, E Sahalchyk, A Astrauko, S Hoffner, ... Bulletin of the World Health Organization 91, 36-45, 2013 | 262 | 2013 |
| Population-based resistance of Mycobacterium tuberculosis isolates to pyrazinamide and fluoroquinolones: results from a multicountry surveillance project M Zignol, AS Dean, N Alikhanova, S Andres, AM Cabibbe, DM Cirillo, ... The Lancet infectious diseases 16 (10), 1185-1192, 2016 | 206 | 2016 |
| Genetic sequencing for surveillance of drug resistance in tuberculosis in highly endemic countries: a multi-country population-based surveillance study M Zignol, AM Cabibbe, AS Dean, P Glaziou, N Alikhanova, C Ama, ... The Lancet Infectious Diseases 18 (6), 675-683, 2018 | 157 | 2018 |
| Monitoring therapy adherence of tuberculosis patients by using video-enabled electronic devices A Story, RS Garfein, A Hayward, V Rusovich, A Dadu, V Soltan, ... Emerging infectious diseases 22 (3), 538, 2016 | 97 | 2016 |
| Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden country HE Jenkins, V Plesca, A Ciobanu, V Crudu, I Galusca, V Soltan, ... European Respiratory Journal 42 (5), 1291-1301, 2013 | 95 | 2013 |
| Drug-resistant tuberculosis in the WHO European Region: an analysis of surveillance data M Zignol, M Dara, AS Dean, D Falzon, A Dadu, K Kremer, H Hoffmann, ... Drug Resistance Updates 16 (6), 108-115, 2013 | 82 | 2013 |
| Factors associated with unfavorable treatment outcomes in new and previously treated TB patients in Uzbekistan: a five year countrywide study J Gadoev, D Asadov, M Tillashaykhov, K Tayler-Smith, P Isaakidis, ... PloS one 10 (6), e0128907, 2015 | 76 | 2015 |
| Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011 DJ Ulmasova, G Uzakova, MN Tillyashayhov, L Turaev, W Van Gemert, ... Eurosurveillance 18 (42), 20609, 2013 | 63 | 2013 |
| Video-observed treatment for tuberculosis patients in Belarus: findings from the first programmatic experience H Sinkou, H Hurevich, V Rusovich, L Zhylevich, D Falzon, ... European Respiratory Journal 49 (3), 2017 | 61 | 2017 |
| Epidemiology of tuberculosis in WHO European Region and public health response M Dara, A Dadu, K Kremer, R Zaleskis, HHP Kluge European Spine Journal 22, 549-555, 2013 | 59 | 2013 |
| Drug-resistant tuberculosis in Eastern Europe: challenges and ways forward CD Acosta, A Dadu, A Ramsay, M Dara Public Health Action 4 (2), S3-S12, 2014 | 54 | 2014 |
| Alarming levels of multidrug-resistant tuberculosis in Ukraine: results from the first national survey E Pavlenko, A Barbova, A Hovhannesyan, Z Tsenilova, A Slavuckij, ... The International Journal of Tuberculosis and Lung Disease 22 (2), 197-205, 2018 | 49 | 2018 |
| Drug-resistant tuberculosis in eastern Europe and central Asia: a time-series analysis of routine surveillance data A Dadu, A Hovhannesyan, S Ahmedov, MJ van der Werf, M Dara The Lancet Infectious Diseases 20 (2), 250-258, 2020 | 41 | 2020 |
| Determinants of site of tuberculosis disease: an analysis of European surveillance data from 2003 to 2014 G Sotgiu, D Falzon, V Hollo, C Ködmön, N Lefebvre, A Dadu, ... PloS one 12 (11), e0186499, 2017 | 41 | 2017 |
| Progress toward tuberculosis control and determinants of treatment outcomes—Kazakhstan, 2000–2002 E Bumburidi, S Ajeilat, A Dadu, I Aitmagambetova, J Ershova, R Fagan, ... Morbidity and Mortality Weekly Report 55, S11-S15, 2006 | 32 | 2006 |
| First national survey of anti-tuberculosis drug resistance in Azerbaijan and risk factors analysis N Alikhanova, I Akhundova, M Seyfaddinova, E Mammadbayov, ... Public Health Action 4 (2), S17-S23, 2014 | 29 | 2014 |
| Policies and practices on the programmatic management of latent tuberculous infection: global survey Y Hamada, A Sidibe, A Matteelli, A Dadu, MA Aziz, M Del Granado, ... The International Journal of Tuberculosis and Lung Disease 20 (12), 1566-1571, 2016 | 18 | 2016 |
| Stopping TB in Europe: some progress but still not there D Falzon, Y Kudjawu, JC Desenclos, K Fernandez de la Hoz, A Dadu, ... Eurosurveillance 13 (12), 3-4, 2008 | 15 | 2008 |
Jan DrobeniucMicrobiologist, Centers for Disease Control and Prevention, Atlanta, GA, USAVerified email at cdc.gov
